0001209191-22-024918.txt : 20220420 0001209191-22-024918.hdr.sgml : 20220420 20220420160541 ACCESSION NUMBER: 0001209191-22-024918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220419 FILED AS OF DATE: 20220420 DATE AS OF CHANGE: 20220420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bjarke Henric Bjorn CENTRAL INDEX KEY: 0001652179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39397 FILM NUMBER: 22838059 MAIL ADDRESS: STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inozyme Pharma, Inc. CENTRAL INDEX KEY: 0001693011 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475129768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-330-4340 MAIL ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Inozyme Pharma, LLC DATE OF NAME CHANGE: 20161222 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-19 0 0001693011 Inozyme Pharma, Inc. INZY 0001652179 Bjarke Henric Bjorn C/O INOZYME PHARMA, INC. 321 SUMMER STREET SUITE 400 BOSTON MA 02210 0 1 0 0 SVP, COO Common Stock 2022-04-19 4 P 0 27100 3.69 A 80626 D /s/ Henric Bjarke 2022-04-20